AbbVie seeks lift from ‘guided missile’ cancer drug with $10 billion ImmunoGen deal
Post Content
Similar Posts
For eastern Ukrainians, the ordeal of war is entering its second decade
Post Content Post Views: 56
Berkshire Hathaway shifts portfolio, exits Procter & Gamble and Johnson & Johnson
Post Content Post Views: 53
Metro Bank in Talks to Sell £3 Billion Mortgage Portfolio to Barclays
Post Content Post Views: 50
Verisk Analytics shares dip as market shows mixed results
Post Content Post Views: 53
Gaza truce is not enough, say residents of bombed-out neighbourhood
Post Content Post Views: 47
JP Morgan boosts target prices for Indian two-wheeler stocks
Post Content Post Views: 51